Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum

Annals of Neurology

Volumn 55, Issue 6, 2004, Pages 815-828

  Mesulam, Marsel ^a   Shaw, Pamela ^a   Mash, Deborah ^b   Weintraub, Sandra ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZ 50 ANTIBODY; ANTIBODY; AT 8 ANTIBODY; CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE INHIBITOR; DIRECT YELLOW 7; TAU ANTIBODY; THIOFLAVINE; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; COGNITIVE DEFECT; CORRELATION ANALYSIS; CYTOPATHOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLE; NEUROPSYCHOLOGICAL TEST; OLIVARY NUCLEUS; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; TAUOPATHY;

ACETYLCHOLINE; ACETYLTRANSFERASES; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BASAL NUCLEUS OF MEYNERT; CASE-CONTROL STUDIES; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HISTOLOGICAL TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDIES; MALE; NEUROFIBRILLARY TANGLES; NEUROPSYCHOLOGICAL TESTS; POSTMORTEM CHANGES; TAU PROTEINS; THIAZOLES;

EID: 2542511697     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20100     Document Type: Article

References (42)

1. Davies P, Maloney AJF. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976;2:1943.
2. Bowen DM, Smith CB, White P, Davison AN. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 1976;99:459-496.
3. Mesulam M-M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learning Memory 2004;11:43-49.
4. Geula C, Mesulam M-M. Cholinergic systems in Alzheimer's disease. In: Terry RD, Katzman R, Bick KL, Sisodia SS, eds. Alzheimer disease. 2nd ed. Philadelphia: Lippincott, 1999:269-292.
5. Davis KL, Mohs RC, Marin D, et al. Cholinergic markers in elderly patients with early signs of Alzheimer's disease. JAMA 1999;281:1401-1406.
6. DeKosky ST, Ikonomovic MD, Styren SD, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145-155.
7. Gilmor ML, Erickson JD, Varoqui H, et al. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 1999;411:693-704.
8. Mufson EJ, Ma SY, Dills J, et al. Loss of basal forebrain P75ntr immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 2002;443:136-153.
9. Mufson EJ, Cochran EJ, Bennett DA, et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 2000;427:19-30.
10. Folstein M, Folstein S, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
11. Morris JC, Heyman A, Mohs RC, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
12. Wechsler D. WAIS-R manual. New York: Psychological Corporation, 1981.
13. Benton AL. Revised Visual Retention Test. 4th ed. New York: Psychological Corporation, 1974.
14. Benton A, Hamsher KdS. Multilingual Aphasia Examination. Iowa City, IA: University of Iowa, 1989.
15. Craik FIM, Salthouse T. The handbook of cognitive aging. Mahwah, NJ: Lawrence Erlbaum, 2000.
16. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-2391.
17. Ivnik RJ, Malec JF, Smith GE, et al. Neuropsychological tests' norms above age 55: COWAT, BNT, MAE Token, WRAT-R Reading, AMNART, Stroop, TMT, and JLO. Clin Neuropsychol 1996;10:262-278.
18. Ivnik RJ, Malec JF, Smith GE, et al. Mayo's older Americans normative studies: WMS-R norms for ages 56 through 94. Clin Neuropsychol 1992;6(suppl):49-82.
19. Spreen O, Strauss E. A compendium of neuropsychological tests. New York: Oxford University Press, 1998.
20. Mesulam M-M, Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol 1988;275:216-240.
21. German DC, Bruce G, Hersh LB. Immunohistochemical staining of cholinergic neurons in the human brain using a polyclonal antibody to human choline acetyltransferase. Neurosci Lett 1985;61:1-5.
22. Hyman BT, Van Hoesen GW, Wolozin BL, et al. Alz-50 antibody recognizes Alzheimer-related neuronal changes. Ann Neurol 1988;23:371-379.
23. Braak E, Braak H, Mandelkow E-M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994;87:554-567.
24. García-Sierra F, Ghoshal N, Quinn B, et al. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J Alzheimer Dis 2003;5:65-77.
25. Augustinack JC, Schneider A, Mandelkow E-M, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 2002;103:26-35.
26. Guillozet AL, Smiley JF, Mash DC, Mesulam M-M. Butyryl-cholinesterase in the life cycle of amyloid plaques. Ann Neurol 1997;42:909-918.
27. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand 1996;165(suppl):3-12.
28. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
29. Luis CA, Loewenstein DA, Acevedo A, et al. Mild cognitive impairment: directions for future research. Neurology 2003;61:438-444.
30. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment. Clinical characterization and outcome. Arch Neurol 1999;56:303-308.
31. Gold PE. Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learning Memory 2003;80:194-210.
32. Sarter M, Bruno JP. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brain-stem afferents. Neuroscience 2000;95:933-952.
33. Su JH, Cummings BJ, Cotman CW. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 1994;5:2358-2362.
34. Gamblin TC, Chen F, Zambrano A, et al. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Nat Acad Sci USA 2003;100:10032-10037.
35. Carmel G, Mager EM, Binder LI, Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 1996;271:32789-32795.
36. Sassin I, Schultz C, Thal DR, et al. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 2000;100:259-269.
37. Hatanpää K, Brady DR, Stoll J, et al. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1996;40:411-420.
38. Mesulam M-M. The systems-level organization of cholinergic innervation in the cerebral cortex and its alterations in Alzheimer's disease. Prog Brain Res 1996;109:285-298.
39. Geula C, Mesulam M-M. Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study. Neuroscience 1989;33:469-481.
40. Kuhl DE, Minoshima S, Fessler JA, et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol 1996;40:399-410.
41. Morris JC, Price JL. Pathological correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 2001;17:101-118.
42. Guillozet AL, Weintraub S, Mash DC, Mesulam M-M. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003;60:729-736.